publishedAt,title,description
2018-01-01,2018.  It announced its second-quarter interim dividend of $0.34 on April 26 and paid it on June 1.  It announced its third-quarter interim dividend of $0.34 on June 28 and paid it on September 4.	https://finance.yahoo.com/m/cc762594-ab3e-33d0-b35d-235b71dcb78d/pfizer%E2%80%99s-earnings-quality-and.html?.tsrc=rss,2018.  It announced its second-quarter interim dividend of $0.34 on April 26 and paid it on June 1.  It announced its third-quarter interim dividend of $0.34 on June 28 and paid it on September 4.	https://finance.yahoo.com/m/cc762594-ab3e-33d0-b35d-235b71dcb78d/pfizer%E2%80%99s-earnings-quality-and.html?.tsrc=rss
2018-01-01,2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...	https://finance.yahoo.com/news/klein-law-firm-reminds-investors-150000098.html?.tsrc=rss,2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...	https://finance.yahoo.com/news/klein-law-firm-reminds-investors-150000098.html?.tsrc=rss
2018-01-01,2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...	https://finance.yahoo.com/news/klein-law-firm-reminds-investors-183746659.html?.tsrc=rss,2018-- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead ...	https://finance.yahoo.com/news/klein-law-firm-reminds-investors-183746659.html?.tsrc=rss
2018-01-01,2018.	https://finance.yahoo.com/m/58babf8f-05a5-3a5e-8034-39e75021fb79/analysts%E2%80%99-recommendations-for.html?.tsrc=rss,2018.	https://finance.yahoo.com/m/58babf8f-05a5-3a5e-8034-39e75021fb79/analysts%E2%80%99-recommendations-for.html?.tsrc=rss
2018-01-01,2018 /PRNewswire/ – AbbVie (ABBV) announced today global resolution of all intellectual property-related litigation with Samsung Bioepis over its proposed biosimilar adalimumab product.	https://finance.yahoo.com/news/abbvie-announces-global-resolution-humira-120500818.html?.tsrc=rss,2018 /PRNewswire/ – AbbVie (ABBV) announced today global resolution of all intellectual property-related litigation with Samsung Bioepis over its proposed biosimilar adalimumab product.	https://finance.yahoo.com/news/abbvie-announces-global-resolution-humira-120500818.html?.tsrc=rss
2019-01-01,"2019 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) (""""AbbVie"""") announced today that the requisite number of consents have been received to adopt certain proposed amendments ...""	https://finance.yahoo.com/news/abbvie-announces-results-early-participation-014100999.html?.tsrc=rss","2019 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) (""""AbbVie"""") announced today that the requisite number of consents have been received to adopt certain proposed amendments ...""	https://finance.yahoo.com/news/abbvie-announces-results-early-participation-014100999.html?.tsrc=rss"
2021-01-01,2021.	https://finance.yahoo.com/news/allergan-aesthetics-present-data-leading-130000647.html?.tsrc=rss,2021.	https://finance.yahoo.com/news/allergan-aesthetics-present-data-leading-130000647.html?.tsrc=rss
2023-01-01,2023.	https://finance.yahoo.com/news/abbvie-settles-novartis-delay-humira-132301813.html?.tsrc=rss,2023.	https://finance.yahoo.com/news/abbvie-settles-novartis-delay-humira-132301813.html?.tsrc=rss
